Nutritional support therapies nutrition

Gene expression inhibition. Chloroform/ methanol extract (1 1) of the dried leaf, in cell culture, was active on hepatoma-Cos-7, IC50 600.0 pg/mL vs TAT-dependent activation of HIV promoter hioassay - . Hepatotoxic activity. The leaf, taken orally by a female adult, was active - . A patient consumed 15 tablets of the leaf per day for 4 months. Approximately 1 year after stopping consumption, liver enzymes returned to normal and fatigue was no longer a complaint - ". Infusion of the dried leaf, taken orally by a female adult at variable doses, was active. The 60-year-old woman who took Lama tridentata for 10 months developed severe hepatitis for which no other cause could be found. Despite aggressive supportive therapy, the patient s condition deteriorated and required orthotropic liver transplantation - " . Dried leaves, administered orally to adults at variable doses, were active. A public warning has been issued by the US Centers for Disease Control based on reports of liver toxicity after use of Lama tridentata tea - " k Dried leaves, administered orally to adults of both sexes at variable doses, were active - ". The plant, administered orally to adults at variable doses, was active - ". Dried leaves, administered orally to adults at variable doses, were active. One case of hepatotoxicity induced by Larrea tridentata taken as a nutritional supplement was reported - ". Thirteen patients were identified for whom Larrea tridentata tincture for internal use was prescribed. Additionally, 20 female and three male patients were identified from whom an extract of Larrea tridentata in castor oil for... 

Patients at risk for nutritional deficit are given nutritional support therapy to replace nutrients. Nutritional support therapy provides nutrients before there is a negative nitrogen balance to assure there is a positive nitrogen balance, enabling the patient to fight infectious diseases. 

Preparation (Table 11.1) given to patients receiving enteral nutritional support therapy depends on the nutrient, caloric values, and osmolality that the patient requires. These preparations are grouped as ... 

Parenteral nutrition support therapy is used for disorders of the GI track, bums, and debilitating disease. Parenteral nutrition support therapy is administered through a central venous line (subclavian or internal jugular veins) to prevent irritation to the peripheral veins. 

Parenteral nutrition support therapy preparation contains ... 

Complications from parenteral nutrition support therapy are ... 

Caution Do not suddenly interrupt parenteral nutrition support therapy. The patient can experience hypoglycemia. Discontinue gradually by decreasing the infusion rate. Monitor for hypoglycemia. 

Enteral nutritional support therapy occurs when food is administered by mouth or a feeding tube that leads directly into the stomach or small intestine. 

Parenteral nutritional support therapy is a means of providing high caloric nutrients administered through large veins such as the subclavian vein. 

What is another name for parenteral nutritional support therapy ... 

Parenteral nutritional support therapy does not promote GI function, liver function, or weight gain. 

A patient might experience uncontrolled vomiting and aspiration during enteral nutritional support therapy because the GI motility and small bowel are not functioning. 

What is the blenderized group of enteral nutritional support therapy preparations ... 

Name three common lactose-free liquid polymeric enteral nutritional support therapy preparations. Three common lactose-free liquid polymeric enteral nutritional support therapy preparations are Ensure, Isocal, and Osmolite. 

Name three complications of enteral nutritional support therapy. 

Three complications of enteral nutritional support therapy are dehydration, aspiration, and diarrhea. 

---